ETF

Xtrackers MSCI Genomic HC Inno ETF 1C

ISIN
IE000KD0BZ68

How good is this fund, really?

See the rating in the app

About Xtrackers MSCI Genomic HC Inno ETF 1C

How much weight a company gets in Xtrackers MSCI Genomic HC Inno ETF 1C depends on both its size and how closely its business ties to genomic healthcare innovation. The ETF follows the MSCI ACWI IMI Genomic Innovation Select Screened 100 Index, drawn from global large, mid and small caps in the MSCI ACWI IMI Index that earn, or are expected to earn, significant revenue from the theme. ESG screening removes breaching companies, the top 100 by market value are chosen, and no issuer may exceed 4.5% at a rebalance. DWS buys all or most constituents and can lend securities under ESG rules. Gains stay in the fund. The KIID gives risk category 6 of 7 and a 0.30% ongoing charge for this share class from 2022.

Watch this fund for free Add Xtrackers MSCI Genomic HC Inno ETF 1C to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy Xtrackers MSCI Genomic HC Inno ETF 1C — platforms and fees

Sold on one platform we follow.

Xtrackers MSCI Genomic HC Inno ETF 1C — its category

Sector Equity Healthcare — PowerFunds rates 229 funds in this category every month.

Healthcare funds →

Other funds